Diampa 25 Tablet

About Diampa 25 Tablet

Diampa 25 is a 25 mg tablet made by Renata PLC. It contains empagliflozin and belongs to a group of medicines called SGLT2 inhibitors, which are used in adults with type 2 diabetes.

There are 23 brands of Empagliflozin listed in Bangladesh. The lowest listed price is Adempa 10 mg Tablet at ৳ 25.00 per unit.

What is Diampa 25 Tablet?

Diampa 25 is a 25 mg tablet containing empagliflozin, made by Renata PLC. It is a sodium-glucose cotransporter-2 (SGLT2) inhibitor. This kind of medicine works on the kidneys, where it reduces the reabsorption of glucose and increases the amount of glucose passed out in the urine. It is used in adults with type 2 diabetes alongside diet and exercise. It can also be used to lower the risk of cardiovascular death in adults with type 2 diabetes who already have established cardiovascular disease. Whether it suits you depends on your health and other medicines, so your doctor will decide.

Uses of Diampa 25

Diampa 25 is used in adults with type 2 diabetes as an add-on to diet and exercise to help improve blood sugar control. It is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes who have established cardiovascular disease. It is not a replacement for healthy eating and physical activity. Your doctor will explain whether this medicine is appropriate for your condition.

How to use Diampa 25

Diampa 25 is a tablet that is swallowed. Your doctor decides the dose and the course that are right for you, so follow their instructions exactly. Do not change the dose yourself. If you are not sure how or when to take it, or what to do if you miss a dose, ask your doctor or pharmacist. They can also tell you how to store it properly.

Side effects of Diampa 25

The most common side effects of empagliflozin are urinary tract infections and fungal infections of the female genital area. Other common side effects include dehydration, low blood pressure, weakness, dizziness and increased thirst. If you notice any side effect, or if something worries you, tell your doctor or pharmacist. They can advise you on what to do and whether any change in your treatment is needed.

Safety and precautions

Do not use Diampa 25 if you have had a serious allergic reaction to empagliflozin or to any of its ingredients. It is not for people with severe kidney problems, end-stage kidney disease or those on dialysis. Tell your doctor about your kidney function, other medicines such as diuretics, insulin or medicines that raise insulin, and any illness or surgery. It is not recommended while breastfeeding. Use in pregnancy only if the doctor decides the benefit outweighs the risk. Ask your doctor first if you are pregnant, planning a pregnancy or breastfeeding, or if you have any doubts.

Frequently asked questions

What is Diampa 25 used for and what kind of medicine is it?

Diampa 25 is an SGLT2 inhibitor containing empagliflozin. It is used in adults with type 2 diabetes, along with diet and exercise, to improve blood sugar control. It is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

How should Diampa 25 be taken?

Diampa 25 is a tablet that is swallowed. The dose and the length of treatment are decided by your doctor, so follow their instructions exactly and do not change the dose yourself. Ask your doctor or pharmacist if you are unsure about anything, including what to do if you miss a dose.

Who should avoid Diampa 25 or ask the doctor first?

Do not take it if you have had a serious allergic reaction to empagliflozin or any ingredient, or if you have severe kidney problems, end-stage kidney disease or are on dialysis. Ask your doctor first if you are pregnant, planning a pregnancy or breastfeeding, or take diuretics, insulin or other diabetes medicines.

What should I tell my doctor before starting Diampa 25?

Tell your doctor about all your health conditions, especially kidney problems, and about every medicine you take, including diuretics, insulin and other diabetes medicines. Also mention if you are pregnant, planning a pregnancy or breastfeeding. Your doctor will check whether this medicine is suitable for you.

Indications

Empagliflozin is indicated in:
  • As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
  • To reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and established cardiovascular disease.

Pharmacology

Empagliflozin is a sodium glucose co-transporter-2 (SGLT-2) inhibitor. SGLT2 co-transporters are responsible for reabsorption of glucose from the glomerular filtrate in the kidney. The glucuretic effect resulting from SGLT2 inhibition reduces renal absorption and lowers the renal threshold for glucose, resulting in increased glucose excretion. Additionally, it contributes to reduced hyperglycaemia, assists weight loss, and reduces blood pressure.

Dosage & Administration

The recommended dose of Empagliflozin is 10 mg once daily, taken in the morning, with or without food. In patients tolerating Empagliflozin, the dose may be increased to 25 mg once daily. In patients with volume depletion, correcting this condition prior to initiation of Empagliflozin is recommended.

Interaction

Diuretics: Co-administration of Empagliflozin with diuretics resulted in increased urine volume. 

Insulin or Insulin Secretagogues: Co-administration of Empagliflozin with insulin or insulin secretagogues increases the risk for hypoglycemia. 

Positive Urine Glucose Test: Monitoring glycemic control with urine glucose tests is not recommended in patients taking SGLT2 inhibitors as SGLT2 inhibitors increase urinary glucose excretion and will lead to positive urine glucose tests. Use alternative methods to monitor glycemic control. 

Interference with 1,5-anhydroglucitol (1,5-AG) Assay: Monitoring glycemic control with 1,5-AG assay is not recommended as measurements of 1,5-AG are unreliable in assessing glycemic control in patients taking SGLT2 inhibitors. Use alternative methods to monitor glycemic control.

Contraindications

Empagliflozin is contraindicated in patients with history of serious hypersensitivity reaction to Empagliflozin or any of its ingredients, severe renal impairment, end-stage renal disease, or dialysis.

Side Effects

The most common adverse reactions associated with Empagliflozin are urinary tract infections and female genital mycotic infections. Others common side effects includes dehydration, hypotension, weakness, dizziness and increased thirstiness.

Pregnancy & Lactation

There are no adequate and well-controlled studies of Empagliflozin in pregnant women. Empagliflozin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known if Empagliflozin is excreted in human milk. It is not recommended when breastfeeding.

Precautions & Warnings

Assessment of renal function is recommended prior to initiation of Empagliflozin and periodically thereafter. Empagliflozin should not initiated in patients with an eGFR less than 45 ml/min/1.73 m2. No dose adjustment is needed in patients with an eGFR greater than or equal to 45 ml/min/1.73 m2.

Overdose Effects

In the event of an overdose with Empagliflozin the usual supportive measures (e.g., remove unabsorbed material from the gastrointestinal tract, perform clinical monitoring, and institute supportive treatment) should be employed. Removal of Empagliflozin by hemodialysis has not been studied.

Storage Conditions

Keep in a cool & dry place (below 30° C), protected from light & moisture. Keep out of the reach of children.

Alternative brands of Empagliflozin

Other brands with the same generic name, cheapest first.

Ajardy Tablet

10 mg

Empagliflozin

Ziska Pharmaceuticals Ltd.

৳ 24.5 ৳ 25.00 2% off per unit

Ajardy Tablet

25 mg

Empagliflozin

Ziska Pharmaceuticals Ltd.

৳ 39.2 ৳ 40.00 2% off per unit

See all 23 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.